MedTrace Logo

Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis

NCT01195116 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2015-04-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the effects of dexmedetomidine while patients undergo treatment for Interstitial Cystitis (IC). The investigators goal is to demonstrate in patients with IC undergoing bladder hydrodistension that the use of dexmedetomidine as a supplemental anesthetic agent will result in better postoperative pain management.

Conditions

  • Interstitial Cystitis

Interventions

DRUG

Dexmedetomidine

1 mcg/kg/hour

DRUG

Normal Saline

1mcg/kg/hr

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Suzanne Karan, MD · University of Rochester Department of Affiliation

  • Robert Mayer, MD · University of Rochester Department of Urology

  • Denham Ward, MD, PhD · University of Rochester Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01195116 on ClinicalTrials.gov